11 employees
Tranquis Therapeutics is focused on the discovery and development of therapies to treat neurodegenerative and aging-related diseases.
2016
$30M
from 4 investors over 4 rounds
Tranquis Therapeutics, Inc. raised $30M on July 9, 2020
Investors: Remiges Ventures, Inc., Correlation Ventures, Vivo Capital and S.R. One Ltd